This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción MPH
Master Pharm SA designs and manufactures diet supplements, special nutritional food, dietary products, cosmetics, medical devices, and other consumables in Poland.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Competidores de Master Pharm SA
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | zł6.05 |
| 52 Week High | zł6.05 |
| 52 Week Low | zł3.85 |
| Beta | 0.58 |
| 1 Month Change | 0% |
| 3 Month Change | 0.83% |
| 1 Year Change | 50.12% |
| 3 Year Change | 8.42% |
| 5 Year Change | 21.98% |
| Change since IPO | -12.32% |
Noticias y actualizaciones recientes
Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)
Feb 05
Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes
Dec 13Recent updates
Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)
Feb 05Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes
Dec 13A Look At The Intrinsic Value Of Master Pharm SA (WSE:MPH)
May 25Master Pharm (WSE:MPH) Will Will Want To Turn Around Its Return Trends
Mar 30Is Master Pharm SA's (WSE:MPH) Latest Stock Performance Being Led By Its Strong Fundamentals?
Mar 02I Ran A Stock Scan For Earnings Growth And Master Pharm (WSE:MPH) Passed With Ease
Feb 04
Master Pharm (WSE:MPH) Is Growing Earnings But Are They A Good Guide?
Jan 08Here's What To Make Of Master Pharm's (WSE:MPH) Returns On Capital
Dec 18Master Pharm SA (WSE:MPH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Nov 27Rentabilidad de los accionistas
| MPH | PL Personal Products | Mercado PL | |
|---|---|---|---|
| 7D | 0% | 0.5% | -0.01% |
| 1Y | 50.1% | 60.2% | 25.7% |
Rentabilidad vs. Industria: MPH exceeded the Polish Personal Products industry which returned -24.9% over the past year.
Rentabilidad vs. Mercado: MPH exceeded the Polish Market which returned -30.5% over the past year.
Volatilidad de los precios
| MPH volatility | |
|---|---|
| MPH Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 4.7% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in PL Market | 10.0% |
| 10% least volatile stocks in PL Market | 3.2% |
Precio estable de las acciones: MPH has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine MPH's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2002 | n/a | Jacek Franasik | www.masterpharm.pl |
Resumen de fundamentos de Master Pharm SA
| Estadísticas fundamentales de MPH | |
|---|---|
| Capitalización bursátil | zł119.72m |
| Beneficios(TTM) | zł1.68m |
| Ingresos (TTM) | zł79.17m |
71.2x
Ratio precio-beneficio (PE)1.5x
Ratio precio-ventas (PS)¿Está MPH sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de MPH | |
|---|---|
| Ingresos | zł79.17m |
| Coste de los ingresos | zł38.67m |
| Beneficio bruto | zł40.50m |
| Otros gastos | zł38.82m |
| Beneficios | zł1.68m |
Últimos beneficios comunicados
Jun 30, 2022
Próxima fecha de beneficios
Nov 17, 2022
| Beneficios por acción (BPA) | 0.085 |
| Margen bruto | 51.15% |
| Margen de beneficio neto | 2.12% |
| Ratio deuda/patrimonio | 16.1% |
¿Cómo se ha desempeñado MPH a largo plazo?
Ver rendimiento histórico y comparativa